氨甲环酸的不同用法在初次单侧全膝关节表面置换术中的作用
Overview
- Phase
- 回顾性研究
- Status
- Completed
- Sponsor
- 国家卫生和计划生育委员会
- Enrollment
- 560
- Locations
- 1
- Primary Endpoint
- Haemoglobin loss
Overview
Brief Summary
目前,暂未有一项研究同时评估氨甲环酸哪种给药途径在降低术后失血量、输血量、额外费用和副作用比如(血栓栓塞的并发症等)方面是最好的。因此,该研究的目的是针对要进行初次单侧全膝表面置换术的患者,同时评估静脉给药、关节局部用药和口服给药中哪种途径对患者最有利。
Study Design
- Study Type
- 观察性研究
- Primary Purpose
- 队列研究
Eligibility Criteria
- Ages
- 47 to 84 (—)
- Sex
- All
Inclusion Criteria
- •膝关节骨关节炎或类风湿性关节炎的患者;初次进行单侧膝关节表面置换术的患者;至少达到 3 周的随访时间;凝血机制正常;内科疾病(比如糖尿病、高血压等)在术前得到有效控制。
Exclusion Criteria
- •要求一次进行双侧膝关节表面置换术的患者;膝关节翻修的患者;患有严重的肝肾、心血管和肺部疾病的患者;凝血性和出血性疾病;以及近期接受抗凝治疗的患者。
Arms & Interventions
intravenous group
The intravenous group received 20mg/kg of TXA administered intravenously 30 minutes before incising skin and the same dose and administration 12 hours postoperatively.
topical group
The topical group received 3.0g TXA (total 60ml solution) administered intra-articularly after subcutaneous tissue was sutured.
oral group
The oral group received 20mg/kg of TXA administered orally 2 hours preoperatively and the same dose and administration 12 hours postoperatively.
blank group
No TXA was used for the blank group.
Outcomes
Primary Outcomes
Haemoglobin loss
Time Frame: 48 hours postoperatively
Drainage volume
Time Frame: 48 hours postoperatively
Transfusion units
Additional cost
Secondary Outcomes
- Tourniquet time
- Thromboembolic complications
- Wound healing